EQUITY-BASED INCENTIVE PLANS - Nonvested Restricted Stock Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
RSAs
Shares
Number of nonvested shares outstanding, beginning	517,569
Nonvested shares granted	296,000
Nonvested shares vested	(62,501)
Nonvested shares forfeited	3,333
Number of nonvested shares outstanding, ending	747,735	517,569
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share)	$ 4.74
Weighted average exercise price outstanding, nonvested options granted (in usd per share)	3.62
Weighted average exercise price outstanding, options vested (in usd per share)	5.21
Weighted average exercise price outstanding, options forfeited (in usd per share)	5.54
Weighted average exercise price outstanding, ending (in usd per share)	$ 4.25	$ 4.74
Unrecognized stock-based compensation expense	$ 2,451
Weighted average remaining vesting period	2 years 1 month 6 days
RSUs
Shares
Number of nonvested shares outstanding, beginning	450,000
Nonvested shares vested	(77,501)
Nonvested shares forfeited		450,000
Number of nonvested shares outstanding, ending	18,770	450,000
Restricted Shares
Nonvested restricted stock outstanding, beginning balance (in shares)	1,014,166
Nonvested restricted stock granted (in shares)	605,000
Nonvested restricted stock vested (in shares)	(15,000)
Nonvested restricted stock forfeited (in shares)	(3,000)
Nonvested restricted stock outstanding, ending balance (in shares)	1,601,166	1,014,166
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share)	$ 3.73
Weighted average exercise price outstanding, nonvested options granted (in usd per share)	3.58
Weighted average exercise price outstanding, options vested (in usd per share)	6.11
Weighted average exercise price outstanding, options forfeited (in usd per share)	5.84
Weighted average exercise price outstanding, ending (in usd per share)	$ 3.64	$ 3.73
Unrecognized stock-based compensation expense	$ 4,456
Weighted average remaining vesting period	2 years 6 months